When experiencing new things, the structure and function of our neurons and their connections are rapidly being remodeled. This process, known as synaptic plasticity, is critical for us to learn and adapt. However, these ...
Jan 4, 2024
0
62
Preeclampsia and other hypertensive disorders of pregnancy—which are characterized by high blood pressure with or without organ dysfunction during the second half of pregnancy—carry considerable short- and long-term risks ...
Jan 3, 2024
0
23
An atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells also has enabled the discovery of a decoy molecule that protects against the potentially deadly brain ...
Jan 3, 2024
0
52
A new protein risk score developed to predict the risk of death for persons with heart failure (HF) has demonstrated good calibration and may help clinicians better stratify mortality risk in these patients. The score is ...
Jan 1, 2024
0
9
Estradiol (E2), a sex steroid hormone, plays an essential role in social behavior, including regulating social anxiety, which is anxiety experienced when unknown individuals are encountered. In males, testosterone secreted ...
Dec 27, 2023
0
0
Billions of years ago, as primitive lifeforms were becoming more complex, a selfish genetic component became a sort of genome colonizer. Using a copy-and-paste mechanism, this pernicious bit of code replicated and inserted ...
Dec 26, 2023
0
187
For a third season, COVID-19 cases are rising ahead of the holidays, this time with a more recent variant driving infections.
Dec 23, 2023
1
0
A new study details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal. The full paper, "Para-infectious brain injury in COVID-19 persists ...
Dec 22, 2023
1
109
Scientists at St. Jude Children's Research Hospital have revealed the complex structure of two Parkinson's disease-related proteins, both of which are implicated in late-onset cases. Leucine-rich repeat kinase 2 (LRRK2) is ...
Dec 21, 2023
0
32
Last month, the U.S. Food and Drug Administration (FDA) approved the use of the drug capivasertib, in combination with a current cancer treatment called fulvestrant for patients with the most common type of breast cancer, ...
Dec 21, 2023
0
0
